Annual FCF
-$70.97 M
-$12.80 M-22.01%
31 December 2023
Summary:
Inozyme Pharma annual free cash flow is currently -$70.97 million, with the most recent change of -$12.80 million (-22.01%) on 31 December 2023. During the last 3 years, it has fallen by -$34.43 million (-94.22%). INZY annual FCF is now -631.98% below its all-time high of -$9.70 million, reached on 31 December 2018.INZY Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$24.54 M
-$883.00 K-3.73%
30 September 2024
Summary:
Inozyme Pharma quarterly free cash flow is currently -$24.54 million, with the most recent change of -$883.00 thousand (-3.73%) on 30 September 2024. Over the past year, it has dropped by -$5.67 million (-30.02%). INZY quarterly FCF is now -622.64% below its all-time high of -$3.40 million, reached on 30 September 2019.INZY Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$91.36 M
-$5.67 M-6.61%
30 September 2024
Summary:
Inozyme Pharma TTM free cash flow is currently -$91.36 million, with the most recent change of -$5.67 million (-6.61%) on 30 September 2024. Over the past year, it has dropped by -$24.53 million (-36.71%). INZY TTM FCF is now -1613.67% below its all-time high of -$5.33 million, reached on 31 March 2019.INZY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.0% | -30.0% | -36.7% |
| 3 y3 years | -94.2% | -98.3% | -99.7% |
| 5 y5 years | -632.0% | -622.6% | -571.1% |
INZY Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -94.2% | at low | -98.3% | +0.1% | -99.7% | at low |
| 5 y | 5 years | -632.0% | at low | -622.6% | +0.1% | -571.1% | at low |
| alltime | all time | -632.0% | at low | -622.6% | +0.1% | -1613.7% | at low |
Inozyme Pharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.54 M(+3.7%) | -$91.36 M(+6.6%) |
| June 2024 | - | -$23.66 M(-3.7%) | -$85.69 M(+10.4%) |
| Mar 2024 | - | -$24.57 M(+32.1%) | -$77.59 M(+9.3%) |
| Dec 2023 | -$70.97 M(+22.0%) | -$18.59 M(-1.5%) | -$70.97 M(+6.2%) |
| Sept 2023 | - | -$18.88 M(+21.3%) | -$66.83 M(+6.7%) |
| June 2023 | - | -$15.56 M(-13.3%) | -$62.61 M(+1.1%) |
| Mar 2023 | - | -$17.95 M(+24.2%) | -$61.94 M(+6.5%) |
| Dec 2022 | -$58.17 M(+19.8%) | -$14.45 M(-1.5%) | -$58.17 M(+1.7%) |
| Sept 2022 | - | -$14.66 M(-1.5%) | -$57.21 M(+4.2%) |
| June 2022 | - | -$14.89 M(+5.0%) | -$54.93 M(+9.3%) |
| Mar 2022 | - | -$14.18 M(+5.1%) | -$50.26 M(+3.5%) |
| Dec 2021 | -$48.55 M | -$13.48 M(+8.9%) | -$48.55 M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$12.38 M(+21.1%) | -$45.76 M(+3.6%) |
| June 2021 | - | -$10.22 M(-18.0%) | -$44.16 M(+3.6%) |
| Mar 2021 | - | -$12.46 M(+16.6%) | -$42.64 M(+16.7%) |
| Dec 2020 | -$36.54 M(+92.8%) | -$10.69 M(-0.9%) | -$36.54 M(+17.2%) |
| Sept 2020 | - | -$10.79 M(+24.0%) | -$31.19 M(+31.1%) |
| June 2020 | - | -$8.70 M(+36.7%) | -$23.80 M(+19.1%) |
| Mar 2020 | - | -$6.37 M(+19.3%) | -$19.98 M(+5.5%) |
| Dec 2019 | -$18.95 M(+95.4%) | -$5.34 M(+57.2%) | -$18.95 M(+39.2%) |
| Sept 2019 | - | -$3.40 M(-30.5%) | -$13.61 M(+33.2%) |
| June 2019 | - | -$4.88 M(-8.4%) | -$10.22 M(+91.6%) |
| Mar 2019 | - | -$5.33 M | -$5.33 M |
| Dec 2018 | -$9.70 M | - | - |
FAQ
- What is Inozyme Pharma annual free cash flow?
- What is the all time high annual FCF for Inozyme Pharma?
- What is Inozyme Pharma annual FCF year-on-year change?
- What is Inozyme Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for Inozyme Pharma?
- What is Inozyme Pharma quarterly FCF year-on-year change?
- What is Inozyme Pharma TTM free cash flow?
- What is the all time high TTM FCF for Inozyme Pharma?
- What is Inozyme Pharma TTM FCF year-on-year change?
What is Inozyme Pharma annual free cash flow?
The current annual FCF of INZY is -$70.97 M
What is the all time high annual FCF for Inozyme Pharma?
Inozyme Pharma all-time high annual free cash flow is -$9.70 M
What is Inozyme Pharma annual FCF year-on-year change?
Over the past year, INZY annual free cash flow has changed by -$12.80 M (-22.01%)
What is Inozyme Pharma quarterly free cash flow?
The current quarterly FCF of INZY is -$24.54 M
What is the all time high quarterly FCF for Inozyme Pharma?
Inozyme Pharma all-time high quarterly free cash flow is -$3.40 M
What is Inozyme Pharma quarterly FCF year-on-year change?
Over the past year, INZY quarterly free cash flow has changed by -$5.67 M (-30.02%)
What is Inozyme Pharma TTM free cash flow?
The current TTM FCF of INZY is -$91.36 M
What is the all time high TTM FCF for Inozyme Pharma?
Inozyme Pharma all-time high TTM free cash flow is -$5.33 M
What is Inozyme Pharma TTM FCF year-on-year change?
Over the past year, INZY TTM free cash flow has changed by -$24.53 M (-36.71%)